Generic Version of Wellbutrin Pulled Off the Market

The FDA has asked Teva Pharmaceuticals to pull its generic version of the popular antidepressant Wellbutrin  XL 300 mg off the market after discovering that the generic version releases its key ingredient faster than the original drug.

The generic version, Budeprion XL 300 mg, was pulled after hundreds of reports that the drug did not work or caused side effects including headaches, anxiety and insomnia.

There are four other generic versions of Wellbutrin XL 300 mg that have been approved by the FDA.

To learn more, click here.